Compound Danshen Dripping Pills clinical trials
Compound Danshen Dripping Pills is named as an intervention in 2 current clinical trials in our China register. 1 is recruiting patients now. All registered phases are Phase 4. The sponsor with the most trials is Qilu Hospital of Shandong University (1). The most-studied condition is Coronary Microvascular Disease.
Patient leaflets for Compound Danshen Dripping Pills
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of Compound Danshen Dripping Pills
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment
NCT07041359 · ClinicalTrials.gov ↗ · Coronary Arterial Disease (CAD)
|
Phase 4 | Recruiting | China National Center for Cardiovascular Diseases | China |
|
Coronary MicrovAscular Diseases Intervention With Compound Danshen Dropping Pills
NCT07885462 · ClinicalTrials.gov ↗ · Coronary Microvascular Disease
|
Phase 4 | Not yet open | Qilu Hospital of Shandong University | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Compound Danshen Dripping Pills
2 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Qilu Hospital of Shandong University | 1 |
| China National Center for Cardiovascular Diseases | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 1 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Compound Danshen Dripping Pills trials
How many clinical trials are testing Compound Danshen Dripping Pills?
2 current trials in our China register name Compound Danshen Dripping Pills as a drug or biological intervention, as of the registry sync on 22 October 2026. Completed and withdrawn studies are not counted.
Are Compound Danshen Dripping Pills trials recruiting patients?
Yes. 1 of the 2 trials is recruiting: 1 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Compound Danshen Dripping Pills clinical trials?
Qilu Hospital of Shandong University (1) and China National Center for Cardiovascular Diseases (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Compound Danshen Dripping Pills works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Compound Danshen Dripping Pills works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Compound Danshen Dripping Pills (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 22 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.